Next-Generation Sequencing Explained: NGS Technologies, DNA and RNA Sequencing Methods, Genomic Analysis, Global Manufacturers, Suppliers and Clinical Applications
Next-generation sequencing (NGS) is an advanced molecular technology used to determine the sequence of DNA and RNA molecules by analyzing millions of genetic fragments simultaneously. It has become an important tool in genomics, biotechnology, pharmaceutical research, molecular diagnostics, and clinical laboratories.
Traditional DNA sequencing methods generally analyze individual DNA fragments, whereas next-generation sequencing systems process large numbers of genetic fragments in parallel. This development has expanded the scale of genomic research and enabled laboratories to investigate complex genetic information more efficiently. Different sequencing platforms use distinct chemical reactions, detection methods, sample preparation procedures, and computational systems.
Understanding NGS technologies requires knowledge of DNA and RNA sequencing methods, library preparation, sequencing instruments, genomic data analysis, and clinical applications. This guide examines major sequencing technologies, whole-genome and targeted sequencing, global equipment manufacturers, laboratory suppliers, bioinformatics platforms, industry developments, regulatory considerations, and the factors involved in evaluating genomic analysis systems.
Understanding Next-Generation Sequencing Technology
Next-generation sequencing refers to a group of high-throughput technologies that determine the order of nucleotide bases in DNA or RNA. DNA contains four primary nucleotide bases: adenine, thymine, cytosine, and guanine. RNA uses uracil instead of thymine.
NGS allows laboratories to examine large numbers of genetic fragments during a single sequencing run. The resulting information can help researchers identify genetic variations, investigate gene expression, study microorganisms, and understand biological processes.
Unlike conventional Sanger sequencing, which generally analyzes individual DNA fragments, NGS uses massively parallel sequencing methods. This approach supports large-scale genomic investigations and different types of molecular testing.
NGS workflows generally involve five major stages:
Sample collection and nucleic acid extraction.
DNA or RNA quality assessment.
Library preparation and sample indexing.
Sequencing and signal detection.
Bioinformatics processing and genomic interpretation.
Each stage contributes to the quality and reliability of the final sequencing data.
Main Types of Next-Generation Sequencing Technologies
NGS platforms use different technologies to identify nucleotide sequences. Their differences involve sequencing chemistry, detection systems, read length, throughput, accuracy, and laboratory requirements.
Sequencing by Synthesis
Sequencing by synthesis (SBS) identifies DNA bases through controlled nucleotide incorporation during DNA strand formation.
In widely used short-read SBS systems, fluorescently labelled reversible terminator nucleotides are incorporated into growing DNA strands. Optical instruments detect the incorporated bases through imaging, and the process continues through repeated sequencing cycles.
This technology supports whole-genome sequencing, whole-exome sequencing, targeted gene panels, and RNA sequencing.
Illumina is a major manufacturer associated with sequencing-by-synthesis technology.
Sequencing by Ligation
Sequencing by ligation identifies nucleotide sequences through the interaction of short DNA probes with template DNA.
The method uses ligase enzymes to connect complementary probes, while fluorescent signals help determine the sequence information.
Although sequencing by ligation has been important in the development of high-throughput sequencing, its use is more limited in contemporary commercial NGS workflows compared with sequencing-by-synthesis and other technologies.
Semiconductor Sequencing
Semiconductor sequencing detects changes associated with hydrogen ions released during nucleotide incorporation.
Instead of using fluorescence-based optical detection, semiconductor instruments measure chemical signals through specialized sensors.
Ion Torrent technology, associated with Thermo Fisher Scientific, uses this approach. It has applications in targeted sequencing, microbial analysis, and selected clinical and research workflows.
Single-Molecule Real-Time Sequencing
Single-Molecule Real-Time (SMRT) sequencing is a long-read technology developed by Pacific Biosciences, commonly known as PacBio.
It observes DNA synthesis at the level of individual DNA molecules. The technology can generate long sequence reads, supporting genome assembly, structural variant detection, and analysis of complex genomic regions.
SMRT sequencing is particularly relevant when conventional short reads cannot provide sufficient information about repetitive sequences or large structural changes.
Nanopore Sequencing
Nanopore sequencing identifies DNA or RNA molecules by measuring changes in electrical current as nucleic acids pass through biological or synthetic nanopores.
Oxford Nanopore Technologies develops sequencing systems based on this principle.
Nanopore technology supports long-read sequencing, portable sequencing instruments, real-time data generation, and direct RNA sequencing applications.
Comparison of Major NGS Technologies
| Technology | Detection principle | Main applications |
|---|---|---|
| Sequencing by synthesis | Fluorescent nucleotide detection | Whole-genome and targeted sequencing |
| Sequencing by ligation | Probe ligation and signal detection | Specialized sequencing workflows |
| Semiconductor sequencing | Hydrogen-ion detection | Targeted genomic analysis |
| SMRT sequencing | Real-time single-molecule observation | Long-read genome analysis |
| Nanopore sequencing | Electrical current changes | Long-read DNA and RNA analysis |
DNA and RNA Sequencing Methods
DNA sequencing and RNA sequencing investigate different aspects of biological information. The choice depends on whether the objective is to identify genetic variations or examine gene activity.
Whole-Genome Sequencing
Whole-genome sequencing (WGS) examines a large proportion of an organism's complete genomic DNA.
It can identify different categories of genetic variation, including single-nucleotide variants, insertions, deletions, copy-number changes, and structural variations, depending on the platform and analytical workflow.
WGS is used in inherited disease research, cancer genomics, population genetics, microbial genomics, and comparative genomic studies.
Whole-Exome Sequencing
Whole-exome sequencing (WES) focuses on the protein-coding regions of the genome, known as exons.
Although these regions represent a relatively small portion of the complete human genome, they contain many known disease-associated variants.
WES is commonly used in rare genetic disease investigations, inherited disorder research, and clinical genomic analysis.
Targeted Gene Panel Sequencing
Targeted sequencing examines selected genes or genomic regions associated with a particular research or diagnostic objective.
For example, oncology panels may examine genes associated with specific cancers, while inherited disease panels focus on genes linked to particular genetic conditions.
Targeted sequencing generally produces a more focused dataset than whole-genome sequencing.
RNA Sequencing
RNA sequencing, commonly called RNA-Seq, examines RNA molecules to understand gene expression and transcript structure.
It helps researchers identify expressed genes, alternative splicing, transcript variations, and certain gene fusion events.
Applications include cancer research, developmental biology, pharmaceutical studies, and gene expression profiling.
Single-Cell Sequencing
Single-cell sequencing investigates genetic information or gene expression at the individual cell level.
Traditional bulk sequencing combines genetic material from many cells, potentially hiding differences between individual cell populations.
Single-cell DNA sequencing and single-cell RNA sequencing help researchers study cellular diversity, immune cell populations, tumour heterogeneity, and developmental processes.
NGS Library Preparation and Genomic Analysis Process
Library preparation is an essential stage of NGS because it converts extracted DNA or RNA into a format compatible with the sequencing platform.
Sample Extraction and Quality Assessment
DNA or RNA is extracted from biological materials such as blood, tissue, cultured cells, microorganisms, or other samples.
Laboratories assess nucleic acid concentration, purity, and integrity before beginning library preparation.
Poor-quality samples can affect sequencing coverage, library complexity, and downstream analysis.
DNA Fragmentation and Library Construction
DNA may be fragmented into smaller pieces using mechanical or enzymatic methods.
Sequencing adapters are then attached to the DNA fragments. These adapters help the fragments interact with the sequencing instrument and may contain sample-specific index sequences.
For RNA sequencing, RNA is commonly converted into complementary DNA (cDNA) before library construction.
Sequencing and Data Generation
Prepared libraries are loaded onto a sequencing instrument. The instrument detects signals generated by nucleotide incorporation or molecular movement, depending on the platform.
The resulting output consists of sequence reads that represent portions of the original genetic material.
Bioinformatics and Variant Analysis
Bioinformatics software processes sequencing reads and converts raw signals into interpretable genomic information.
Common analytical stages include:
Base calling and quality assessment.
Sequence alignment or genome assembly.
Variant identification and classification.
Gene expression analysis.
Structural variation detection.
Biological interpretation and report preparation.
Data analysis is an essential part of NGS because sequencing results require computational processing before meaningful biological conclusions can be established.
Global NGS Manufacturers, Suppliers and Technology Providers
The NGS industry includes manufacturers of sequencing instruments, reagent suppliers, library preparation companies, laboratory equipment providers, and bioinformatics developers.
Major international companies include:
Illumina: Develops short-read sequencing instruments, sequencing reagents, and genomic analysis technologies.
Thermo Fisher Scientific: Supplies Ion Torrent sequencing systems, molecular biology equipment, and laboratory reagents.
Pacific Biosciences: Develops SMRT long-read sequencing platforms and associated genomic technologies.
Oxford Nanopore Technologies: Manufactures nanopore sequencing instruments, flow cells, and sequencing-related software.
Roche: Develops molecular diagnostic technologies, sequencing-related solutions, and genomic research systems.
QIAGEN: Supplies nucleic acid extraction technologies, sample preparation products, and molecular biology solutions.
BGI Genomics: Provides genomic sequencing technologies and large-scale sequencing-related research capabilities.
Agilent Technologies: Supplies laboratory instruments, genomic analysis equipment, and sample preparation technologies.
IDT (Integrated DNA Technologies): Provides oligonucleotides, custom DNA products, and library preparation components.
10x Genomics: Develops technologies for single-cell analysis, spatial biology, and multiomic research.
These companies operate across different parts of the genomic technology supply chain. Their products and systems serve research laboratories, biotechnology companies, pharmaceutical organizations, and clinical testing facilities.
Clinical and Industrial Applications of NGS
NGS has applications across healthcare, pharmaceutical research, biotechnology, agriculture, and environmental science.
Clinical Genetics and Inherited Disorders
NGS helps investigate inherited genetic conditions by identifying variants associated with hereditary diseases.
Whole-exome sequencing and whole-genome sequencing can support investigations when conventional genetic testing does not identify an underlying molecular cause.
Clinical interpretation requires appropriate laboratory validation, medical assessment, and consideration of family history.
Cancer Genomic Profiling
Cancer cells can contain genetic alterations that influence tumour development, progression, and treatment response.
NGS-based tumour profiling can identify selected mutations, gene fusions, and other genomic biomarkers. These findings may help clinicians assess molecular characteristics and evaluate treatment options.
Liquid biopsy sequencing can also examine circulating tumour DNA in blood samples for selected clinical and research applications.
Infectious Disease Research
NGS supports the identification and genomic characterization of bacteria, viruses, fungi, and other microorganisms.
It is used in pathogen surveillance, outbreak investigations, antimicrobial resistance research, and microbial genome analysis.
Pharmaceutical and Biotechnology Research
Pharmaceutical researchers use NGS to investigate drug response, genetic biomarkers, disease pathways, and molecular mechanisms.
RNA sequencing and genomic profiling can also support drug discovery, clinical research, and companion diagnostic development.
Agricultural and Environmental Genomics
NGS technologies are used in crop genetics, livestock research, plant disease investigation, biodiversity studies, and environmental microbiology.
Metagenomic sequencing can examine microbial communities in soil, water, food, and other environmental samples.
Industry Developments and Trends During 2024–2026
The NGS industry continues to develop through improvements in sequencing chemistry, long-read technologies, laboratory automation, and computational analysis.
Important developments include:
Long-read sequencing expansion: SMRT and nanopore technologies are supporting research involving complex genomic regions, structural variations, and full-length transcripts.
Single-cell genomics: Improved sequencing workflows are expanding research into individual cell populations and cellular differences.
Spatial transcriptomics: Emerging methods combine gene expression information with the spatial organization of cells within tissue samples.
Laboratory automation: Automated sample preparation and library construction help laboratories manage larger sequencing workloads.
Artificial intelligence in genomics: Computational methods are increasingly being explored for variant prioritization, sequence interpretation, and genomic data analysis.
Faster sequencing workflows: New instrument designs and sequencing chemistries are targeting shorter processing times and more integrated laboratory workflows.
In February 2025, Roche announced its sequencing-by-expansion technology, introducing another approach to high-throughput DNA sequencing. Developments in this area demonstrate continued diversification of commercial sequencing technologies.
Regulations, Quality Standards and Clinical Laboratory Requirements
NGS laboratories must consider regulatory requirements, quality management, sample handling, and data protection.
Clinical sequencing systems may require appropriate regulatory authorization depending on their intended use and the country where they operate. Research-use-only instruments and reagents should not automatically be treated as validated clinical diagnostic products.
Important quality frameworks include:
ISO 15189: Requirements for quality and competence in medical laboratories.
ISO 13485: Quality management requirements for medical device organizations.
CLIA: United States federal requirements for applicable clinical laboratory testing.
CAP accreditation: Laboratory accreditation framework used by clinical laboratories.
Data protection requirements: Rules governing patient genomic information, privacy, and authorized data access.
In India, clinical laboratories must consider applicable clinical establishment requirements, laboratory quality standards, medical device regulations where relevant, and patient data protection obligations.
Genomic testing also raises ethical considerations involving informed consent, incidental findings, family-related genetic information, and long-term data storage.
Important Factors When Evaluating NGS Systems
Selecting sequencing instruments, reagents, and laboratory suppliers requires evaluating several technical and operational factors.
Sequencing throughput: Determine the number of samples and quantity of sequence data required for each run.
Read length: Short-read and long-read technologies have different capabilities for detecting genetic variations and resolving complex genomic regions.
Sequencing accuracy: Evaluate platform-specific accuracy, coverage requirements, error profiles, and validation data.
Sample compatibility: Confirm whether the workflow supports DNA, RNA, formalin-fixed tissue, blood, microbial samples, or other required materials.
Library preparation: Examine reagent compatibility, workflow complexity, sample input requirements, and automation options.
Bioinformatics infrastructure: Consider data storage, computing capacity, software compatibility, cybersecurity, and genomic interpretation capabilities.
Supplier support: Review equipment installation, technical training, reagent availability, maintenance arrangements, and documentation.
Clinical suitability: For diagnostic applications, evaluate intended use, laboratory validation, regulatory status, and reporting requirements.
Frequently Asked Questions
What is next-generation sequencing used for?
Next-generation sequencing is used to analyze DNA and RNA in genetic research, cancer profiling, inherited disease investigations, infectious disease studies, and gene expression analysis. It also supports pharmaceutical research, agriculture, and microbial genomics.
What is the difference between DNA sequencing and RNA sequencing?
DNA sequencing examines the nucleotide sequence of genetic material and can identify inherited or acquired genetic variations. RNA sequencing examines RNA molecules to investigate gene expression, transcript structures, and certain gene fusion events.
What are the major NGS technology manufacturers?
Major companies include Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies, Roche, QIAGEN, BGI Genomics, and Agilent Technologies.
What is the difference between whole-genome sequencing and whole-exome sequencing?
Whole-genome sequencing examines a broad portion of the complete genome, including coding and non-coding regions. Whole-exome sequencing focuses primarily on protein-coding regions and is commonly used in inherited disease investigations.
Is NGS used in clinical diagnostics?
Yes. NGS is used in selected clinical applications involving inherited disorders, cancer genomic profiling, and infectious disease analysis. Clinical use requires appropriate validation, quality controls, and professional interpretation of the results.
Conclusion
Next-generation sequencing has transformed genomic research by enabling large-scale DNA and RNA analysis through parallel sequencing technologies. Sequencing by synthesis, semiconductor detection, SMRT, and nanopore technologies provide different approaches for genomic investigation. Applications extend across clinical genetics, oncology, infectious disease research, pharmaceutical development, agriculture, and biotechnology. Understanding sequencing methods, sample preparation, bioinformatics, regulatory requirements, and equipment supplier capabilities is essential when evaluating NGS platforms and genomic analysis systems.